UNGAP best practice for improving solubility data quality of orally administered drugs

An important goal of the European Cooperation in Science and Technology (COST) Action UNGAP (UNderstanding Gastrointestinal Absorption-related Processes, www.ungap.eu) is to improve standardization of methods relating to the study of oral drug absorption. Solubility is a general term that refers to the maximum achievable concentration of a compound dissolved in a liquid medium.

For orally administered drugs, relevant information on drug properties is crucial during drug (product) development and at the regulatory level. Collection of reliable and reproducible solubility data requires careful application and understanding of the limitations of the selected experimental method.

In addition, the purity of a compound and its solid state form, as well as experimental parameters such as temperature of experimentation, media related factors, and sample handling procedures can affect data quality. In this paper, an international consensus developed by the COST UNGAP network on recommendations for collecting high quality solubility data for the development of orally administered drugs is proposed.

Download the full article as a PDF here or read it here

Article information: M Vertzoni, J Alsenz, P Augustijns, A Bauer-Brandl, CAS Bergström, J Brouwers, A Müllerz, G Perlovich, C Saal, K Sugano, C Reppas, UNGAP best practice for improving solubility data quality of orally administered drugs, European Journal of Pharmaceutical Sciences, 2021. https://doi.org/10.1016/j.ejps.2021.106043.


See more of the interesting UNGAP activities here:

Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics
Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics
Amorphous Solid Dispersions
Amorphous Solid Dispersions
You might also like